CHCT — Community Healthcare Trust Incorporated stock price, charts and financials
QT52Community Healthcare Trust IncorporatedCommunity Healthcare Trust Incorporated (NYSE: CHCT) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 162.04 | EPS (ttm) | 0.11 | Insider Own | 11.08% | Shs Outstand | 28.57M | Perf Week | -2.55% |
| Market Cap | 523.15M | Forward P/E | 31.03 | EPS next Y | 0.59 | Insider Trans | 0.00% | Shs Float | 25.25M | Perf Month | -0.38% |
| Enterprise Value | 1.09B | PEG | 1.15 | EPS next Q | - | Inst Own | - | Short Float | 3.81% | Perf Quarter | 6.33% |
| Income | 6.43M | P/S | 4.28 | EPS this Y | 318.18% | Inst Trans | - | Short Ratio | 4.87 | Perf Half Y | 8.22% |
| Sales | 122.37M | P/B | 1.17 | EPS next Y | 28.26% | ROA | 0.60% | Short Interest | 962.29K | Perf YTD | 11.51% |
| Book/sh | - | P/C | 8.86 | EPS next 5Y | - | ROE | 1.41% | 52W High | 19.12 -4.49% | Perf Year | 16.25% |
| Cash/sh | - | P/FCF | 9.43 | EPS past 3/5Y | -54.28% -37.32% | ROIC | 3.77% | 52W Low | 13.19 38.40% | Perf 3Y | -49.28% |
| Dividend Est. | 1.92 (10.51%) | EV/EBITDA | 13.82 | Sales past 3/5Y | 7.28% 9.75% | Gross Margin | 62.80% | Volatility | 1.83% 2.22% | Perf 5Y | -63.06% |
| Dividend TTM | 1.91 (10.43%) | EV/Sales | 8.87 | EPS Y/Y TTM | 147.83% | Oper. Margin | 31.25% | ATR (14) | 0.41 | Perf 10Y | -20.15% |
| Dividend Ex-Date | May 11, 2026 | Quick Ratio | 272.33 | Sales Y/Y TTM | 6.03% | Profit Margin | 4.95% | RSI (14) | 49.56 | Recom | 2.63 |
| Dividend Gr. 3/5Y | 2.22% 2.27% | Current Ratio | 272.33 | EPS Q/Q | -87.27% | SMA20 | -0.39% | Beta | 0.66 | Target Price | 18.50 |
| Payout | 892.49% | Debt/Eq | 1.34 | Sales Q/Q | 6.67% | SMA50 | 1.89% | Rel Volume | 0.85 | Prev Close | 18.31 |
| Employees | 35 | LT Debt/Eq | 0.65 | Earnings | Aug 04 | SMA200 | 9.74% | Avg Volume | 196.55K | Price | 18.26 |
| IPO Date | May 21, 2015 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -30.00% 0.78% | Net Debt/EBITDA | 7.16 | Volume | 166,832 | Change | -0.27% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-21-26 | Reiterated | Piper Sandler | Neutral | $19 → $20 |
| Feb-19-26 | Reiterated | Evercore ISI Group | In Line | $18 → $17 |
| Jan-20-26 | Reiterated | Truist Securities | Buy | $19 → $20 |
| Aug-13-25 | Reiterated | Truist Securities | Buy | $23 → $19 |
| Oct-31-24 | Reiterated | Piper Sandler | Neutral | $18 → $19 |
| Sep-16-24 | Upgrade | Evercore ISI Group | Underperform → In Line | $43 → $18 |
| Sep-09-24 | Reiterated | Piper Sandler | Neutral | $18 |
| Jul-31-24 | Downgrade | Evercore ISI Group | In Line → Underperform | |
| May-02-24 | Downgrade | Piper Sandler | Overweight → Neutral | |
| May-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
Community Healthcare Trust Incorporated is a real estate investment trust. It focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of December 31, 2025, the Company had investments of approximately 1.2 billion US dollars in 198 real estate properties (including one property with sales-type leases and one property classified as held for sale). The properties are in 36 states, totaling approximately 4.5 million square feet in the aggregate. Community Healthcare Trust Incorporated was incorporated in 2014 in Maryland, USA.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 123 | 121 | 116 | 113 | 98 | 91 | 76 | 61 | 49 | |
| Cost of Goods Sold Incl. D&A | 46 | 111 | 23 | 21 | 17 | 15 | 14 | 12 | 10 | |
| Gross Profit | 77 | 10 | 93 | 92 | 81 | 75 | 62 | 49 | 39 | |
| Selling, General and Administrative Excl. Other | 26 | 25 | 19 | 27 | 15 | 12 | 9 | 8 | 6 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 13 | -35 | 54 | 40 | 32 | 31 | 25 | 22 | 19 | |
| Operating Income | 37 | 20 | 20 | 25 | 34 | 33 | 28 | 19 | 13 | |
| Interest Expense | 30 | 34 | 24 | 18 | 12 | 11 | 9 | 9 | 6 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -3 | 19 | 0 | 1 | 0 | 0 | 0 | 0 | -4 | |
| Net Income Before Taxes | 6 | 5 | -3 | 8 | 22 | 23 | 19 | 10 | 3 | |
| Income Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -2 | |
| Consolidated Net Income | 6 | 5 | -3 | 8 | 22 | 22 | 19 | 8 | 4 | |
| Net Income From Continuing Operations | 6 | 5 | -3 | 8 | 22 | 22 | 19 | 8 | 4 | |
| Net Income | 6 | 5 | -3 | 8 | 22 | 22 | 19 | 8 | 4 | |
| EPS (Recurring) | 0.11 | 0.08 | -0.23 | 0.20 | 0.81 | 0.87 | 0.80 | 0.37 | 0.25 | |
| EPS (Basic, Before Extraordinaries) | 0.11 | 0.08 | -0.23 | 0.20 | 0.81 | 0.87 | 0.80 | 0.37 | 0.25 | |
| EPS (Diluted) | 0.11 | 0.08 | -0.23 | 0.20 | 0.81 | 0.87 | 0.80 | 0.37 | 0.25 | |
| EBITDA | 79 | 83 | 64 | 66 | 67 | 64 | 53 | 42 | 34 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 166.00 | 212.14 | — | 133.20 | 44.20 | 54.33 | 58.89 | 115.84 | 115.32 | |
| Price To Sales Ratio | 4.01 | 3.66 | 4.47 | 5.89 | 8.77 | 11.95 | 13.64 | 13.35 | 10.59 | |
| Gross Margin | 62.60 | 8.26 | 80.17 | 81.42 | 82.65 | 82.42 | 81.58 | 80.33 | 79.59 | |
| Operating Margin | 30.08 | 16.53 | 17.24 | 22.12 | 34.69 | 36.26 | 36.84 | 31.15 | 26.53 | |
| Net Margin | 4.88 | 4.13 | -2.59 | 7.08 | 22.45 | 24.18 | 25.00 | 13.11 | 8.16 | |
| Shares Outstanding | 27 | 27 | 27 | 25 | 24 | 23 | 22 | 19 | 18 | |
| Market Capitalization | 493 | 443 | 519 | 666 | 859 | 1,087 | 1,036 | 814 | 519 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Cotman Cathrine | Director | Nov 04 '25 | Buy | 14.66 | 4,000 | 58,640 | 37,635 | Nov 05 |
| Van Horn R. Lawrence | Director | May 28 '25 | Buy | 16.37 | 11,815 | 193,412 | 88,502 | May 30 |
| Dupuy David H. | CEO and President | May 13 '25 | Buy | 16.23 | 10,000 | 162,300 | 458,500 | May 14 |
| Cotman Cathrine | Director | Apr 30 '25 | Sale | 17.09 | 3,000 | 51,270 | 20,861 | May 02 |
| Cotman Cathrine | Director | Apr 30 '25 | Buy | 17.10 | 3,000 | 51,300 | 23,861 | May 02 |
| Van Horn R. Lawrence | Director | Sep 09 '24 | Buy | 16.13 | 10,000 | 161,300 | 62,230 | Sep 10 |
| Cotman Cathrine | Director | Aug 13 '24 | Buy | 17.72 | 2,000 | 35,440 | 20,861 | Aug 14 |
| Hensley Robert Z | Director | Aug 05 '24 | Buy | 19.50 | 6,500 | 126,750 | 70,670 | Aug 06 |
| Van Horn R. Lawrence | Director | Aug 05 '24 | Buy | 19.42 | 2,500 | 48,550 | 52,230 | Aug 06 |
| Dupuy David H. | CEO and President | Aug 05 '24 | Buy | 19.48 | 10,000 | 194,800 | 363,565 | Aug 06 |
| Van Horn R. Lawrence | Director | Mar 10 '23 | Buy | 36.43 | 685 | 24,955 | 34,193 | Mar 13 |
| Cotman Cathrine | Director | Mar 10 '23 | Buy | 36.24 | 277 | 10,038 | 5,155 | Mar 13 |
| GULMI CLAIRE M | Director | Mar 09 '23 | Buy | 36.77 | 2,042 | 75,084 | 26,140 | Mar 13 |
| Gardner Alan | Director | Mar 09 '23 | Buy | 36.74 | 2,700 | 99,198 | 48,325 | Mar 13 |
| GULMI CLAIRE M | Director | May 07 '20 | Buy | 38.81 | 2,500 | 97,025 | 9,537 | May 08 |